Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
non-cancer COVID-19 versus cancer with COVID-19:none
Sponsors
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
23 Years to 94 Years
Inclusion criteria
Inclusion criteria: 1. tumor group: (1) Aged >=18 years; (2) Diagnosed as a malignant tumor or has a history of malignant tumors before enrollment; (3) The diagnosis and treatment of new coronavirus pneumonia was issued in the seventh edition of the New Coronary Virus Pneumonia Diagnosis and Treatment Plan (trial implementation of the seventh edition) issued by the seventh edition of the National Health Committee in March 2020; (4) Life expectancy is at least 2 years. 2. Control group (non-tumor group): (1) Aged >=18 years; (2) no history of malignant tumors; (3) No basic diseases such as diabetes, coronary heart disease, pneumonia, chronic bronchitis; (4) The diagnosis and treatment of new coronavirus pneumonia was issued by the Seventh Edition of the National Health Committee of the People's Republic of China in March 2020 in the "Diagnosis and Treatment of New Coronavirus Pneumonia (Trial Version 7)"; (5) Life expectancy is at least 2 years.
Exclusion criteria
Exclusion criteria: (1) Those who do not meet the inclusion criteria of this study; (2) Complicated with severe primary heart, liver, and kidney disease; (3) Patients during perioperative period (within 7 days after operation); (4) Immune dysfunction diseases (such as systemic lupus erythematosus) in the active phase; (5) Those who lack clinical data or cannot obtain accurate data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| lynphocyte;cytokine;cancer history;order of severity; | — |
Countries
China
Contacts
Public ContactZhihua Wang, Xianglin Yuan
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology(HUST)
Outcome results
None listed